18 juni 2020 Sweden
Key appointments being made at new diabetes vaccine facility in Umeå
Construction of Diamyd Medical’s new vaccine manufacturing unit in Umeå is now underway, with a number of key roles being actively recruited to help staff the new facility. Newly-appointed site manager Maja Johansson is responsible for establishing the process for the production of GAD, the active substance in the study drug Diamyd
®.
“We are convinced that our facility in Umeå will be world-leading and increase Umeå’s growing reputation as a biotech hub,” says Maja Johansson.
Read the press release here
Information som presenteras här är inte pressmeddelanden och kan innehålla utdrag ur och länkar till externt publicerat innehåll. Diamyd Medical ansvarar inte för externt publicerat innehåll.